BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27281627)

  • 1. Cachexia in Radiotherapy-Treated Patients With Head and Neck Cancer: A Phenomenon That Should Be Investigated.
    Mazzola R; Fiorentino A; Alongi F
    JAMA Oncol; 2016 Jun; 2(6):831. PubMed ID: 27281627
    [No Abstract]   [Full Text] [Related]  

  • 2. Cachexia in Radiotherapy-Treated Patients With Head and Neck Cancer-Reply.
    Grossberg AJ; Mohamed AS; Fuller CD
    JAMA Oncol; 2016 Jun; 2(6):831-2. PubMed ID: 27281628
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of total parenteral nutrition in the patient with cancer.
    Harrison LE; Brennan MF
    Curr Probl Surg; 1995 Oct; 32(10):833-917. PubMed ID: 7555042
    [No Abstract]   [Full Text] [Related]  

  • 4. [Muscle wasting (sarcopenia/cachexia) and malnutrition: new insights into development and therapy].
    Rensing L; Ockenga J
    Dtsch Med Wochenschr; 2010 Aug; 135(33):1605-11. PubMed ID: 20717865
    [No Abstract]   [Full Text] [Related]  

  • 5. Cachexia and sarcopenia: mechanisms and potential targets for intervention.
    Argilés JM; Busquets S; Stemmler B; López-Soriano FJ
    Curr Opin Pharmacol; 2015 Jun; 22():100-6. PubMed ID: 25974750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. For an operational definition of cachexia.
    Pepersack T
    Lancet Oncol; 2011 May; 12(5):423-4. PubMed ID: 21536223
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre.
    Lees J
    Eur J Cancer Care (Engl); 1999 Sep; 8(3):133-6. PubMed ID: 10763643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrition impact symptoms and weight loss in head and neck cancer during radiotherapy: a longitudinal study.
    Jin S; Lu Q; Sun Y; Xiao S; Zheng B; Pang D; Yang P
    BMJ Support Palliat Care; 2021 Mar; 11(1):17-24. PubMed ID: 32019753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer.
    Chasen MR; Bhargava R
    Support Care Cancer; 2009 Nov; 17(11):1345-51. PubMed ID: 19618218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More than 10% weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life.
    Langius JA; van Dijk AM; Doornaert P; Kruizenga HM; Langendijk JA; Leemans CR; Weijs PJ; Verdonck-de Leeuw IM
    Nutr Cancer; 2013; 65(1):76-83. PubMed ID: 23368916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial.
    Munshi A; Pandey KC; Susheela SP
    Radiother Oncol; 2006 Jan; 78(1):109-10; author reply 108-9. PubMed ID: 16307815
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation.
    van den Berg MG; Rasmussen-Conrad EL; Gwasara GM; Krabbe PF; Naber AH; Merkx MA
    Clin Nutr; 2006 Oct; 25(5):765-72. PubMed ID: 16698130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of weight loss for cancer patients receiving radiotherapy.
    Lau SKM; Iyengar P
    Curr Opin Support Palliat Care; 2017 Dec; 11(4):261-265. PubMed ID: 28914642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of weight loss during conformal radiotherapy for head and neck cancers - how important are planning target volumes?
    Mallick I; Gupta SK; Ray R; Sinha T; Sinha S; Achari R; Chatterjee S
    Clin Oncol (R Coll Radiol); 2013 Sep; 25(9):557-63. PubMed ID: 23651866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cachexia update in head and neck cancer: Definitions and diagnostic features.
    Couch ME; Dittus K; Toth MJ; Willis MS; Guttridge DC; George JR; Barnes CA; Gourin CG; Der-Torossian H
    Head Neck; 2015 Apr; 37(4):594-604. PubMed ID: 24415363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planning target volumes determine weight loss in highly conformal radiation therapy in head and neck cancers--a validation study.
    Gupta SK; Mallick I; Ray R; Shrimali RK; Achari R; Chatterjee S
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):668. PubMed ID: 24908569
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer cachexia syndrome in head and neck cancer patients: Part II. Pathophysiology.
    George J; Cannon T; Lai V; Richey L; Zanation A; Hayes DN; Shores C; Guttridge D; Couch M
    Head Neck; 2007 May; 29(5):497-507. PubMed ID: 17390378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advantage of early induction of opioid to control pain induced by irradiation in head and neck cancer patients.
    Takase H; Sakata T; Yamano T; Sueta T; Nomoto S; Nakagawa T
    Auris Nasus Larynx; 2011 Aug; 38(4):495-500. PubMed ID: 21277720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: is it an underestimated phenomenon? A radiation oncologist's perspective.
    Cacicedo J; Dal Pra A; Alongi F; Navarro A
    Eur J Clin Nutr; 2015 Jul; 69(7):757-60. PubMed ID: 25920425
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.
    Couch ME; Dittus K; Toth MJ; Willis MS; Guttridge DC; George JR; Chang EY; Gourin CG; Der-Torossian H
    Head Neck; 2015 Jul; 37(7):1057-72. PubMed ID: 24634283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.